Latour invests in Anolytech
Summary
Investment AB Latour (publ) has, through its subsidiary Latour Future Solutions AB, signed an agreement to invest in Anolytech Holding AB (Anolytech).Anolytech has developed a circular system for producing effective disinfection, AnoDes, based on natures own disinfectant hypochlorous acid, which is a natural part of the immune system of humans and animals. The companys system is offered as a packaged service to customers in industrial food production, agriculture with animal husbandry, hotels and real estate, and within health care. Anolytech offers a bio-based circular system that effectively prevents unwanted bacteria and viruses from spreading via our water", says Pelle Mattisson, CEO Latour Future Solutions AB. "With Latour as a long-term partner, we get the opportunity to grow further internationally, and at the same time strengthen our established position within sustainable solutions for disinfection", continues Stefan Fischlein, founder of Anolytech.The investment will be made via a directed share issue in Anolytech Holding AB, where Latour Future Solutions AB enters as a 31.8 per cent minority owner of the company.For further information, please contact: Pelle Mattisson, CEO, Latour Future Solutions AB, +46 705 80 06 57 Fredrika Ekman, Investment Director, Investment AB Latour, +46 72 584 93 43Latour Future Solutions is an investment area within Latour that targets sustainability-focused growth companies. The investment portfolio consists of ten substantial holdings with a market value of about SEK 62 billion.